Microdose Therapy for Treatable Diseases

Through microdose therapy, Helen Foundation offers a unique approach to managing and treating a variety of chronic pain diseases. Our goal is to improve your quality of life by relieving many of the symptoms you may struggle with on a day-to-day basis.

Understanding Hydrocortisone Microdose Therapy

Hydrocortisone microdose therapy leverages the anti-inflammatory properties of hydrocortisone in small, precise amounts. This approach minimizes the risk of potential side effects commonly associated with standard treatments, while effectively targeting and relieving inflammation.

Here at Helen Foundation, our dedicated team has refined this therapy, making it a successful option for patients dealing with a wide array of inflammatory conditions.

Our Spectrum of Care

We provide individualized care and targeted treatment for a range of treatable diseases, including the following:

Inflammatory Diseases

Our microdose therapy serves as an effective method for managing and treating various inflammatory diseases, such as arthritis, asthma, dementia, fibromyalgia, MS, osteoarthritis, and Parkinson’s disease.

Arthritis and Rheumatoid Arthritis

Arthritis causes inflammation in the joints leading to pain, stiffness, and decreased mobility. Our therapy helps manage these symptoms, giving patients a chance at a more comfortable life.


Fibromyalgia, characterized by widespread musculoskeletal pain, fatigue, and tenderness, can be effectively managed through hydrocortisone microdose therapy. This approach offers a new perspective to managing these symptoms, leading to improved daily living.

Multiple Sclerosis

Multiple Sclerosis impacts the central nervous system, leading to inflammation and subsequent damage. Microdose therapy helps manage the inflammation associated with this disease, reducing the impact of symptoms on patient’s lives.


Osteoarthritis, the most common form of arthritis, involves degradation of joint cartilage and the underlying bone. Our practice provides relief from the inflammation and pain associated with this condition.

Parkinson’s Disease

Though primarily a neurodegenerative disorder, Parkinson’s disease progression is influenced by inflammation. Our therapy provides a unique approach to managing these symptoms, ultimately improving patient quality of life.

At Helen Foundation, we’re committed to delivering patient-centered care using innovative therapeutic approaches like hydrocortisone microdose therapy. Get in touch with us today and take the first step towards taking control of your inflammatory condition.